ACLX
Price
$63.75
Change
-$1.86 (-2.83%)
Updated
Feb 21 closing price
Capitalization
3.45B
25 days until earnings call
BHVN
Price
$36.91
Change
-$2.86 (-7.19%)
Updated
Feb 21 closing price
Capitalization
3.73B
25 days until earnings call
Ad is loading...

ACLX vs BHVN

Header iconACLX vs BHVN Comparison
Open Charts ACLX vs BHVNBanner chart's image
Arcellx
Price$63.75
Change-$1.86 (-2.83%)
Volume$630.31K
Capitalization3.45B
Biohaven
Price$36.91
Change-$2.86 (-7.19%)
Volume$836.32K
Capitalization3.73B
ACLX vs BHVN Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BHVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. BHVN commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Hold and BHVN is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (ACLX: $63.75 vs. BHVN: $36.91)
Brand notoriety: ACLX and BHVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 99% vs. BHVN: 86%
Market capitalization -- ACLX: $3.45B vs. BHVN: $3.73B
ACLX [@Biotechnology] is valued at $3.45B. BHVN’s [@Biotechnology] market capitalization is $3.73B. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileBHVN’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • BHVN’s FA Score: 0 green, 5 red.
According to our system of comparison, ACLX is a better buy in the long-term than BHVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 4 TA indicator(s) are bullish while BHVN’s TA Score has 3 bullish TA indicator(s).

  • ACLX’s TA Score: 4 bullish, 3 bearish.
  • BHVN’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ACLX is a better buy in the short-term than BHVN.

Price Growth

ACLX (@Biotechnology) experienced а -2.27% price change this week, while BHVN (@Biotechnology) price change was -10.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

ACLX is expected to report earnings on May 08, 2025.

BHVN is expected to report earnings on May 09, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BHVN($3.73B) has a higher market cap than ACLX($3.45B). BHVN YTD gains are higher at: -1.178 vs. ACLX (-16.873). ACLX has higher annual earnings (EBITDA): -33.12M vs. BHVN (-841.6M). ACLX has more cash in the bank: 574M vs. BHVN (379M). BHVN has less debt than ACLX: BHVN (29M) vs ACLX (65.3M). ACLX has higher revenues than BHVN: ACLX (156M) vs BHVN (0).
ACLXBHVNACLX / BHVN
Capitalization3.45B3.73B92%
EBITDA-33.12M-841.6M4%
Gain YTD-16.873-1.1781,432%
P/E RatioN/AN/A-
Revenue156M0-
Total Cash574M379M151%
Total Debt65.3M29M225%
FUNDAMENTALS RATINGS
BHVN: Fundamental Ratings
BHVN
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
80
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACLXBHVN
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
69%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 9 days ago
88%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 4 days ago
72%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
65%
Aroon
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Ad is loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BHVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ABCAX21.62-0.09
-0.41%
American Beacon The London Co Inc Eq A
GTMIX15.06-0.08
-0.53%
GMO International Opportunistic Val III
TOVIX15.77-0.10
-0.63%
American Beacon EAM Int Small Cap R5
BALFX35.29-0.35
-0.98%
American Funds American Balanced F1
AFDGX53.46-1.05
-1.93%
American Century Large Cap Equity R5

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with DNLI. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
-2.83%
DNLI - ACLX
49%
Loosely correlated
-3.98%
RCKT - ACLX
47%
Loosely correlated
-3.68%
KYMR - ACLX
46%
Loosely correlated
-1.63%
BEAM - ACLX
45%
Loosely correlated
-8.18%
RCUS - ACLX
45%
Loosely correlated
+3.07%
More

BHVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BHVN has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if BHVN jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHVN
1D Price
Change %
BHVN100%
-7.19%
VCYT - BHVN
43%
Loosely correlated
-4.56%
APGE - BHVN
39%
Loosely correlated
+1.77%
ACLX - BHVN
38%
Loosely correlated
-2.83%
ABSI - BHVN
37%
Loosely correlated
-4.43%
OCUL - BHVN
36%
Loosely correlated
-3.45%
More